LRMR
Price
$3.42
Change
-$0.12 (-3.39%)
Updated
Dec 1, 10:33 AM (EDT)
Capitalization
302.99M
107 days until earnings call
Intraday BUY SELL Signals
SNDX
Price
$19.61
Change
-$0.21 (-1.06%)
Updated
Dec 1, 12:15 PM (EDT)
Capitalization
1.72B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LRMR vs SNDX

Header iconLRMR vs SNDX Comparison
Open Charts LRMR vs SNDXBanner chart's image
Larimar Therapeutics
Price$3.42
Change-$0.12 (-3.39%)
Volume$1.3K
Capitalization302.99M
Syndax Pharmaceuticals
Price$19.61
Change-$0.21 (-1.06%)
Volume$350
Capitalization1.72B
LRMR vs SNDX Comparison Chart in %
LRMR
Daily Signal:
Gain/Loss:
SNDX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LRMR vs. SNDX commentary
Dec 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Hold and SNDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 01, 2025
Stock price -- (LRMR: $3.54 vs. SNDX: $19.82)
Brand notoriety: LRMR and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 27% vs. SNDX: 28%
Market capitalization -- LRMR: $302.99M vs. SNDX: $1.72B
LRMR [@Biotechnology] is valued at $302.99M. SNDX’s [@Biotechnology] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than LRMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 6 bullish TA indicator(s).

  • LRMR’s TA Score: 5 bullish, 5 bearish.
  • SNDX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than LRMR.

Price Growth

LRMR (@Biotechnology) experienced а -0.56% price change this week, while SNDX (@Biotechnology) price change was +13.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.59%. For the same industry, the average monthly price growth was +0.07%, and the average quarterly price growth was +61.14%.

Reported Earning Dates

LRMR is expected to report earnings on Mar 18, 2026.

SNDX is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (+4.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.72B) has a higher market cap than LRMR($303M). SNDX YTD gains are higher at: 49.924 vs. LRMR (-8.527). LRMR has higher annual earnings (EBITDA): -108.21M vs. SNDX (-314.25M). SNDX has more cash in the bank: 469M vs. LRMR (139M). SNDX has less debt than LRMR: SNDX (1.68M) vs LRMR (4.61M). SNDX has higher revenues than LRMR: SNDX (77.9M) vs LRMR (0).
LRMRSNDXLRMR / SNDX
Capitalization303M1.72B18%
EBITDA-108.21M-314.25M34%
Gain YTD-8.52749.924-17%
P/E RatioN/AN/A-
Revenue077.9M-
Total Cash139M469M30%
Total Debt4.61M1.68M275%
FUNDAMENTALS RATINGS
LRMR vs SNDX: Fundamental Ratings
LRMR
SNDX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
91
Overvalued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6037
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (20) in the null industry is significantly better than the same rating for SNDX (91) in the Biotechnology industry. This means that LRMR’s stock grew significantly faster than SNDX’s over the last 12 months.

SNDX's Profit vs Risk Rating (87) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that SNDX’s stock grew similarly to LRMR’s over the last 12 months.

SNDX's SMR Rating (98) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that SNDX’s stock grew similarly to LRMR’s over the last 12 months.

SNDX's Price Growth Rating (37) in the Biotechnology industry is in the same range as LRMR (60) in the null industry. This means that SNDX’s stock grew similarly to LRMR’s over the last 12 months.

SNDX's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for LRMR (100) in the null industry. This means that SNDX’s stock grew significantly faster than LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMRSNDX
RSI
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 19 days ago
87%
Bearish Trend 13 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
LRMR
Daily Signal:
Gain/Loss:
SNDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OMGCX27.100.27
+1.01%
JPMorgan Mid Cap Growth C
APPIX17.220.11
+0.64%
Appleseed Institutional
DESAX27.080.13
+0.48%
DWS ESG Core Equity A
OSCYX24.320.10
+0.41%
Invesco Main Street Small Cap Y
ERLGX19.970.05
+0.25%
Eaton Vance Atlanta Capital Fcs Gr R6

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with MLTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+0.28%
MLTX - LRMR
43%
Loosely correlated
-0.51%
AMLX - LRMR
43%
Loosely correlated
-0.13%
OCUL - LRMR
42%
Loosely correlated
+0.08%
ERAS - LRMR
41%
Loosely correlated
+1.28%
FDMT - LRMR
41%
Loosely correlated
+6.10%
More